Attralus

San Francisco, United States

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

$56.0M raised

Feb 2024

Series B

Top Investors

Vivo CapitalSamsara BioCapitalRedmile GroupBristol-Myers SquibbJanus Henderson Investors

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Attralus raised?

Attralus has raised $56.0M in total funding. The most recent round was Series B. The last funding was announced in February 2024.

Who are Attralus's investors?

Attralus's investors include Vivo Capital, Samsara BioCapital, Redmile Group, Bristol-Myers Squibb, Janus Henderson Investors.

Where is Attralus headquartered?

Attralus is headquartered in San Francisco, United States.

What does Attralus do?

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

What stage is Attralus at?

Attralus is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 6, 2024.

MLA

"Attralus — Funding & Investors." VCBacked, February 6, 2024, https://www.vcbacked.co/company/attralus. Accessed June 4, 2026.

APA

VCBacked. (2024). Attralus — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/attralus

Wikipedia (cite web)

{{cite web |title=Attralus — Funding & Investors |url=https://www.vcbacked.co/company/attralus |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 6, 2024.